McGeorge Anne's Form 4 filing
Dianthus Therapeutics, Inc. (DNTH) · filed Aug 11, 2026
- Accession no.
- 0001779934-26-000004
- Filed
- Aug 11, 2026, 5:15 PM ET
- Trade date
- Aug 10, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $844.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McGeorge AnneCIK 0001779934 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | MOption exerciseAcquired | +1,250 | $19.36 | +$24,200 | 1,250 | Direct | |
| Aug 10, 2026 | Common Stock | MOption exerciseAcquired | +6,500 | $11.20 | +$72,800 | 7,750 | Direct | |
| Aug 10, 2026 | Common Stock | SSaleDisposed | −1,450 | $107.58 | −$155,991 | 6,300 | Direct | |
| Aug 10, 2026 | Common Stock | SSaleDisposed | −2,800 | $108.38 | −$303,464 | 3,500 | Direct | |
| Aug 10, 2026 | Common Stock | SSaleDisposed | −1,800 | $109.30 | −$196,740 | 1,700 | Direct | |
| Aug 10, 2026 | Common Stock | SSaleDisposed | −1,000 | $110.64 | −$110,640 | 700 | Direct | |
| Aug 10, 2026 | Common Stock | SSaleDisposed | −700 | $111.41 | −$77,987 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | MOption exerciseDisposed | −1,250 | $0.00 | $0 | 0 | Direct | |
| Aug 10, 2026 | Common Stock | MOption exerciseDisposed | −6,500 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.